ndd Medical Technologies announced that data from six clinical trials being presented at this week’s American Thoracic Society (ATS) international meeting in Denver was gathered using the EasyOne line of mobile ultrasound spirometry and pulmonary function (PFT) testing equipment.

The EasyOne Pro is also the exclusive PFT testing device for the ongoing 21-center COPDGene Study, funded by the National Institutes of Health (NIH).

"COPDGene chose ndd Medical’s EasyOne Pro because its gas and volume measurements are highly reproducible and accurate due to coupling of the ultrasound technology with a high speed analyzer and other unique technical features," said Robert Jensen, Ph.D., who heads the study’s PFT Quality Assurance.

At ATS, the following poster presentations feature data obtained with ndd’s EasyOne Plus (spirometry), EasyOne Pro (single breath DLCO — PFTs in under 30 minutes) and EasyOne Pro LAB (all of the above plus multiple-breath nitrogen washout):

Relationship of Ventilation Heterogeneity in the Conducting and Acinar Airway Zones with 3He MRI in Elderly Never-Smokers [P249]
Quality of Spirometry in the Workplace [P949]

Measurement of Carbon Monoxide Transfer in the Lung: Comparator Study Between the Sensormedic Vmax and EasyOne Pro Systems [P1094]

Interplay of Socioeconomic Factors in Modulating Lung-Growth and Functions in School Children [P149]

High Level of Agreement Between Home-Based and In-Clinic Spirometry Results in the WISDOM COPD Study [P576]

Exhaled Carbon Monoxide: A Marker of Recent Household Air Pollution Exposure [P533]

"We are pleased that the accuracy of our point-of-service ultrasound technology and its ease of use–requiring no calibration, no altitude adjustment, no maintenance and no disposables other than spirettes and barriettes — makes it the ideal tool for researchers and clinicians," said Georg Harnoncourt, CEO of ndd Medical Technologies.